Changes of serum interleukin-8, interleukin-22 and tumor necrosis factor-α levels in patients with allergic rhinitis and their relationship with the severity of disease
TIAN Shuangshuang1 LI Qin2
1.Clinical Medicine School, Qingdao University, Shandong Province, Qingdao 266003, China;
2.Department of Otolaryngology, Head and Neck Surgery, Linyi People’s Hospital, Shandong Province, Linyi 276000, China
Abstract：Objective To investigate the changes of serum interleukin -8 (IL-8), IL-22 and tumor necrosis factor-α (TNF-α) levels in patients with allergic rhinitis and their relationship with the severity of disease. Methods Eighty patients with allergic rhinitis who diagnosed and treated in Clinical Medicine School, Qingdao University (“our hospital”for short) from January 2018 to December 2019 were selected as the case group. According to the degree of allergic rhinitis, they were divided into mild rhinitis group (31 cases) and moderate-severe rhinitis group (49 cases). All patients received Budesonide Aerosolized Suspension and Montelukast Sodium Tablets, and the treatment lasted for 12 weeks. Another 80 healthy volunteers in our hospital during the same period were selected as the control group. Serum IL-8, IL-22, and TNF-α levels between the case group and the control group were compared before treatment and 12 weeks after treatment. Serum IL-8, IL-22, TNF-α levels, and score for allergic rhinitis (SFAR) in patients with different degree of allergic rhinitis were compared and the correlation between serum IL-8, IL-22, TNF-α levels, and SFAR score were analyzed. Results Before treatment, IL-8, IL-22, and TNF-α levels in the case group were higher than those in the control group, and the differences were statistically significant (P < 0.05). After 12 weeks of treatment, serum IL-8, IL-22, and TNF-α levels in the case group were lower than those before treatment, and the differences were statistically significant (P < 0.05); there was no significant difference in serum IL-8, IL-22, and TNF-α levels between the case group and the control group (P > 0.05). Serum IL-8, IL-22, and TNF-α levels in moderate-severe rhinitis group were higher than those in mild rhinitis group, and the differences were statistically significant (P < 0.05). SFAR score in moderate-severe rhinitis group was higher than that in mild rhinitis group, and the difference was statistically significant (P < 0.05). Serum IL-8, IL-22 and TNF-α levels were positively correlated with SFAR score (r = 0.825, 0.737, 0.792, P < 0.05). Conclusion Serum IL-8, IL-22 and TNF-α levels in patients with allergic rhinitis are generally elevated, which can be used in the auxiliary diagnosis and disease assessment of allergic rhinitis in clinical practice.
田双双1 李钦2. 过敏性鼻炎患者血清白细胞介素8、白细胞介素22和肿瘤坏死因子-α水平的变化及其与病情严重程度的关系[J]. 中国医药导报, 2021, 18(21): 110-113.
TIAN Shuangshuang1 LI Qin2. Changes of serum interleukin-8, interleukin-22 and tumor necrosis factor-α levels in patients with allergic rhinitis and their relationship with the severity of disease. 中国医药导报, 2021, 18(21): 110-113.
京公网安备 11010502046598号